With a market cap of $26.2 billion, Centene Corporation (CNC) is a managed care company that provides healthcare programs and services to under-insured families and commercial organizations across the United States. It operates through Medicaid, Medicare, Commercial, and Other segments, offering a wide range of services including health insurance, specialty care, pharmacy services, and behavioral health support.
Shares of the Saint Louis, Missouri-based company have underperformed the broader market over the past 52 weeks. CNC stock has decreased nearly 11% over this time frame, while the broader S&P 500 Index ($SPX) has gained 28.5%. However, the stock has increased 29.1% on a YTD basis, outpacing SPX's 6% return.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
In addition, shares of Centene have lagged behind the State Street Health Care Select Sector SPDR ETF's (XLV) 8.3% rise over the past 52 weeks.
www.barchart.com Shares of Centene surged nearly 14% on Apr. 28 after the company reported strong Q1 2026 results, delivering $3.37 in adjusted EPS on $49.9 billion revenue, exceeding estimates. The rally was also driven by improved cost efficiency, as its health benefits ratio fell to 87.3%, supported by lower medical costs, reduced flu-related expenses, and a 50 bps drop in Medicaid HBR. Additionally, investor sentiment strengthened after Centene raised its full-year outlook to $187.5 billion - $191.5 billion in revenue and adjusted EPS above $3.40.
For the fiscal year ending in December 2026, analysts expect CNC's adjusted EPS to climb 66.4% year-over-year to $3.46. The company's earnings surprise history is mixed. It beat the consensus estimates in three of the last four quarters while missing on another occasion.
Among the 20 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on six “Strong Buy” ratings, 13 “Holds,” and one “Strong Sell.”
www.barchart.com On May 4, TD Cowen raised its price target on Centene to $48 while maintaining a “Hold” rating.
As of writing, the stock is trading above the mean price target of $52.75. The Street-high price target of $68 suggests a 28.4% potential upside.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Intel Stock Is Up 190% in 2026 and Trump Says the U.S. Has Made $30 Billion. The Early Innings for INTC May Be Over. 10% Layoffs Won’t Be the End as Zuckerberg Says AI Will Drive More Job Cuts Later This Year So Much for the Software Apocalypse: Atlassian Stock Surges as Data Center Revenue Grows 44% ‘It Has Ticked Off Literally Everybody in the Lending World’: Why Billionaire Steve Eisman Is Shorting This Software Stock